Search results for: 'efficient energy control'

This report examines how decentralized clinical trials (DCTs), enabled by blockchain, digital twins, and artificial intelligence, are reshaping global clinical research. It traces the shift from site-centric to patient-centric models and quantifies the growing scale, globalization, and complexity of clinical trials that make decentralization necess...

The global healthcare IT industry is on track for continuous growth, driven primarily by large-scale technology advancements, organizational readiness, and streamlined adoption. Technological advances and investment in financial, operational, and administrative workflows are expected to reduce the non-medical cost of care and improve the efficiency...

The global healthcare RTLS market is evolving beyond traditional asset tracking toward intelligent location platforms that enable real-time visibility, workflow optimization, and operational decision-making across healthcare environments. As healthcare providers continue investing in digital transformation, RTLS is increasingly being deployed as an...

Carbon nanotubes (CNTs) are emerging as a cornerstone material for next-generation industries, enabling breakthroughs in electric vehicles, aerospace, energy storage, and flexible electronics through their unique combination of lightweight structure, exceptional electrical conductivity, and superior mechanical and thermal performance. Beyond enhanc...

Quantum sensing is transitioning from laboratory research to industrial deployment, driven by the need for ultra-precise, reliable measurement in high-impact sectors such as healthcare, defense, and advanced manufacturing. This shift reflects a broader move from controlled, research-grade environments toward scalable, field-ready systems that meet ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...

Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...

Healthcare systems today are facing a convergence of pressures that threaten both operational stability and patient outcomes. Workforce shortages, clinician burnout, rising costs, and persistent health inequities are compounded by the growing demands of an aging population with complex needs.These challenges are not isolated—they interact and inten...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent technological developments for molecular marker detection, drug delivery, cancer immunotherapies and radiopharmaceuticals. The TOE also comprises analysis of innovations across cell and gene therapy, antibody and gene editing platfo...